ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,099.13
1.23%
US Tech 100
21,614.76
1.64%
Dow Jones
43,134.75
1.30%
Brent Oil
66.755
-4.43%
Bitcoin
105,669.59
0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Lyra Therapeutics Inc (LYRA) Quote

Lyra Therapeutics Inc

Lyra Therapeutics Inc (LYRA)

NASDAQ
13.12
1.63
( 14.19% )
Updated: 15:15:54
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
13.12
Bid
12.93
Ask
13.12
Volume
111,074
11.50 Day's Range 13.36
3.8101 52 Week Range 37.50
Market Cap
17.389M
Previous Close
11.49
Open
11.50
Last Trade
10
@
12.94
Last Trade Time
15:16:39
Financial Volume
$ 1,409,874
VWAP
12.6931
Average Volume (3m)
3,867,769
Shares Outstanding
1,325,345
Dividend Yield
-
PE Ratio
-0.19
Earnings Per Share (EPS)
-70.5
Revenue
1.53M
Net Profit
-93.44M

About Lyra Therapeutics Inc

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
lyratherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was $11.49. Over the last year, Lyra Therapeutics shares have traded in a share price range of $ 3.8101 to $ 37.50.

Lyra Therapeutics currently has 1,325,345 shares outstanding. The market capitalization of Lyra Therapeutics is $15.23 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.19.

Ask ADVFN Intelligence (AI)

LYRA Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 23 2025
LYRA (14.19%)

Form 8-K - Current report
Edgar (US Regulatory)
June 09 2025
LYRA (14.19%)

Form 8-K - Current report
Edgar (US Regulatory)
June 02 2025
LYRA (14.19%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 06 2025
LYRA (14.19%)

Form 8-K - Current report
Edgar (US Regulatory)
May 06 2025
LYRA (14.19%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.7915.798764342511.3313.369.8110837910.60578466CS
48.72198.1818181824.437.53.8101207432820.25468703CS
126.62101.8461538466.537.53.810138677698.04873167CS
264.38550.20034344598.73537.53.810124126238.45057413CS
52-0.57-4.1636230825413.6937.53.810119072819.94987766CS
156-256.88-95.1407407407270349.53.8101101455435.89384702CS
260-543.38-97.6424079066556.58253.810164728362.74804207CS

LYRA - Frequently Asked Questions (FAQ)

What is the current Lyra Therapeutics share price?
The current share price of Lyra Therapeutics is $ 13.12
How many Lyra Therapeutics shares are in issue?
Lyra Therapeutics has 1,325,345 shares in issue
What is the market cap of Lyra Therapeutics?
The market capitalisation of Lyra Therapeutics is USD 15.23M
What is the 1 year trading range for Lyra Therapeutics share price?
Lyra Therapeutics has traded in the range of $ 3.8101 to $ 37.50 during the past year
What is the PE ratio of Lyra Therapeutics?
The price to earnings ratio of Lyra Therapeutics is -0.19
What is the cash to sales ratio of Lyra Therapeutics?
The cash to sales ratio of Lyra Therapeutics is 11.36
What is the reporting currency for Lyra Therapeutics?
Lyra Therapeutics reports financial results in USD
What is the latest annual turnover for Lyra Therapeutics?
The latest annual turnover of Lyra Therapeutics is USD 1.53M
What is the latest annual profit for Lyra Therapeutics?
The latest annual profit of Lyra Therapeutics is USD -93.44M
What is the registered address of Lyra Therapeutics?
The registered address for Lyra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Lyra Therapeutics website address?
The website address for Lyra Therapeutics is lyratherapeutics.com
Which industry sector does Lyra Therapeutics operate in?
Lyra Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NKTRNektar Therapeutics
$ 26.75
(180.40%)
31.81M
ONMDOneMedNet Corporation
$ 0.78
(129.41%)
471.91M
YAASYouxin Technology Ltd
$ 5.57
(95.10%)
18.91M
SOGPSound Group Inc
$ 4.2851
(62.93%)
1.65M
EYENEyenovia Inc
$ 8.80
(60.58%)
40.57M
UPXIUpexi Inc
$ 3.90
(-61.00%)
5.03M
GIBOGIBO Holdings Ltd
$ 0.396
(-30.04%)
24.31M
MAASMaase Inc
$ 6.96
(-29.91%)
1.55M
RBNERobin Energy Ltd
$ 4.8992
(-26.88%)
2.46M
VBIXViewBix Inc
$ 2.94
(-24.03%)
1.02M
ONMDOneMedNet Corporation
$ 0.78
(129.41%)
471.91M
HCTIHealthcare Triangle Inc
$ 0.0323
(4.19%)
319.62M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 13.85
(-3.75%)
196.05M
GNLNGreenlane Holdings Inc
$ 0.0086
(-3.37%)
130.96M
NVDANVIDIA Corporation
$ 147.495
(2.31%)
130.45M

LYRA Discussion

View Posts
makinezmoney makinezmoney 3 weeks ago
$LYRA: Amazing.................... WINNER TODAY, now $30

Looking to see if there was any Unusual Call Option activity leading to this but just WOW.
Only $4 on Friday.

GO $LYRA




*****************************************************************************************************************

Lyra Therapeutics (LYRA) announced positive Phase 3 ENLIGHTEN 2 trial results for LYR-210, a long-acting anti-inflammatory sinonasal implant for chronic rhinosinusitis (CRS). The trial met its primary endpoint, showing statistically significant improvement in three cardinal symptoms at 24 weeks (p=0.0078) in non-polyp patients. Key secondary endpoints were also met, including improvement in SNOT-22 score (p=0.0101). The treatment was well-tolerated with no product-related serious adverse events. Additionally, pooled data from ENLIGHTEN 1 and 2 trials in 64 CRS patients with nasal polyps showed consistent positive trends. While ENLIGHTEN 2 succeeded, ENLIGHTEN 1 did not meet its endpoints. Lyra plans to pursue FDA approval for non-polyp patients and continue development for those with nasal polyps.
👍️0
TrendTrade2016 TrendTrade2016 3 weeks ago
LYRA POST SPLIT MONSTER
👍️ 1
Awl416 Awl416 3 weeks ago
Good lord 
👍️0
shurtha2000 shurtha2000 2 months ago
Moviing
👍️0
shurtha2000 shurtha2000 2 months ago
Remember they are reporting on 2 Trials not just 1
👍️ 1
shurtha2000 shurtha2000 2 months ago
wild swings here
👍️0
Rein07 Rein07 5 months ago
https://finance.yahoo.com/news/lyra-therapeutics-lyra-upgraded-strong-170012660.html
👍️0
glenn1919 glenn1919 6 months ago
lyra.................................https://stockcharts.com/h-sc/ui?s=lyra&p=W&b=5&g=0&id=p86431144783

















lostintheshuffle.......................8
👍️0
tw0122 tw0122 6 months ago
.24
👍️0
tw0122 tw0122 6 months ago
.24
👍️0
Dennis14 Dennis14 10 months ago
Earnings out.
👍️0
Dennis14 Dennis14 10 months ago
Big buys after hours 86000 buy and (3)50000 buys
👍️0
Dennis14 Dennis14 10 months ago
It now says 13th after hours. We will see
👍️0
Dennis14 Dennis14 10 months ago
Earnings supposed to be on the 12th Aug.
👍️0
Dennis14 Dennis14 11 months ago
I just read. Earnings coming out next week or the week after.
👍️0
Dennis14 Dennis14 11 months ago
Earnings coming out any day now.
👍️0
BigBadWolf BigBadWolf 1 year ago
DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
https://lyratherapeutics.com/
👍️0
Zardiw Zardiw 1 year ago
Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

Find Winners Early:



Z
👍️0
Termite7 Termite7 1 year ago
Who? .....How high for LYRA? .......Thanks!!!
👍️0
Zardiw Zardiw 1 year ago
Nice list.........$LYRA is due.......according to #DDAmanda.

Z
👍️0
Termite7 Termite7 1 year ago
Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change
👍️0
Zardiw Zardiw 1 year ago
$LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

Z
👍️ 1
INV4 INV4 1 year ago
LYRA Institutional Holdings
Ownership Summary

Institutional Ownership • 74.73%
Total Shares Outstanding (millions) • 61
Total Value of Holdings (millions) • $16

Active Positions • Holders • Shares
Increased Positions • 54 • 9,224,767
Decreased Positions • 19 • 6,026,566
Held Positions • 11 • 30,304,888

Institutional Holders: 84
Total Shares Held: 45,556,221

$BLEG

LYRA Analyst Research
Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
LYRA Earnings Consensus

CONSENSUS
Buy
Based on 6 analysts offering recommendations for 'LYRA'.

Analyst Price Targets
CONSENSUS
$0.95

Based on analysts offering 12 month price targets for LYRA in the last 3 months.
The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

$LYRA
👍️0
Zardiw Zardiw 1 year ago
$LYRA Bounce anytime now...............

Z
👍️ 1
INV4 INV4 1 year ago
Let's see when it bounces 😀

$LYRA
👍️0
glenn1919 glenn1919 1 year ago
LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783
👍️0
Zardiw Zardiw 1 year ago
Yes. Expecting a nice $LYRA Bounce..............

Z
👍️0
Dennis14 Dennis14 1 year ago
Relative Strength Index is at 12 this is way over sold.
👍️0
Zardiw Zardiw 1 year ago
$LYRA Book Value: $1.28 ....currently at .43 ...

Z
👍️0
Dennis14 Dennis14 1 year ago
Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.
👍️0
axelvento axelvento 1 year ago
game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint
👍️0
Monksdream Monksdream 1 year ago
LYRA under $10

👍️0
Monksdream Monksdream 1 year ago
LYRA under $10
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...NOT HOLDING INTO ER
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...LETS SEE 7.00
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...EXPLODING!!!!!
👍️0
Monksdream Monksdream 1 year ago
LYRA 10Q due March 14
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...BEAUTIFUL BREAK OUT
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA....BIO BEAST!
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...MOVES ON AIR!!!
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...HERE WE GO
👍️0
Monksdream Monksdream 1 year ago
LYRA 10Q due March 7
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA..WHAT A BEAUTY...NOBODY TALKING!!!
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LYRA...NEXT BIO BEAST READY TO BEAST
👍️0
Monksdream Monksdream 2 years ago
LYRA No 3 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

NASDAQ
LYRA
Lyra Therapeutics
Delayed Upgrade Clock
ADVFN
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads